{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:44:26Z","timestamp":1781649866005,"version":"3.54.5"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Ovarian cancer is known to be the most lethal malignancy among all gynecological cancers affecting a large number of women worldwide. The treatment of ovarian cancer is challenging due to the high recurrence rate of the disease and is further complicated by acquired chemoresistance. Most ovarian cancer deaths are the result of the metastatic spread of drug-resistant cells. The theory of cancer stem cells (CSC) suggests that both tumor initiation and progression are driven by a population of undifferentiated capable of self-renewal, tumor initiation and development of chemoresistance. The CD117 mast\/stem cell growth factor receptor (KIT) is the most commonly used marker for ovarian CSCs. Here, we analyze the correlation between CD117 expression and histological tumor type in ovarian cancer cell lines (SK-OV-3 and MES-OV) and in small\/medium extracellular vesicles (EVs) isolated from the urine of ovarian cancer patients. We have demonstrated that the abundance of CD117 on cells and EVs is correlated with tumor grade and therapy resistance status. Moreover, using small EVs isolated from ovarian cancer ascites, it was shown that recurrent disease is characterized by a much higher abundance of CD117 on EVs than primary tumor.<\/jats:p>","DOI":"10.3389\/fcell.2023.1057484","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T11:38:17Z","timestamp":1676547497000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Expression level of CD117 (KIT) on ovarian cancer extracellular vesicles correlates with tumor aggressiveness"],"prefix":"10.3389","volume":"11","author":[{"given":"Polina V.","family":"Shnaider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina Yu.","family":"Petrushanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga I.","family":"Aleshikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya A.","family":"Babaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lev A.","family":"Ashrafyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina I.","family":"Borovkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Dobrokhotova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan M.","family":"Borovkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria O.","family":"Shender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Khomyakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know ovarian cancer ascites: Opportunities for targeted therapy-based translational research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Front. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.molonc.2016.04.002","article-title":"Gene expression profiling of single circulating tumor cells in ovarian cancer - establishment of a multi-marker gene panel","volume":"10","author":"Blassl","year":"2016","journal-title":"Mol. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3390\/nano12091579","article-title":"Highly sensitive nanomagnetic quantification of extracellular vesicles by immunochromatographic strips: A tool for liquid biopsy","volume":"12","author":"Bragina","year":"2022","journal-title":"Nanomater. (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1038\/onc.2012.290","article-title":"c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt\/\u03b2-catenin-ATP-binding cassette G2 signaling","volume":"32","author":"Chau","year":"2013","journal-title":"Oncogene"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1111\/jog.12758","article-title":"Epithelial ovarian cancer with CD117 phenotype is highly aggressive and resistant to chemotherapy","volume":"41","author":"Conic","year":"2015","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e12093","DOI":"10.1002\/jev2.12093","article-title":"Urinary extracellular vesicles: A position paper by the urine task force of the international society for extracellular vesicles","volume":"10","author":"Erdbr\u00fcgger","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"B8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12929-020-00638-x","article-title":"A novel c-Kit\/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and \u03b2-catenin-ABCG2 signaling","volume":"27","author":"Fang","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/biomedicines6010031","article-title":"CD117\/c-kit in cancer stem cell-mediated progression and therapeutic resistance","volume":"6","author":"Foster","year":"2018","journal-title":"Biomedicines"},{"key":"B10","doi-asserted-by":"publisher","first-page":"143; author reply 143","DOI":"10.1038\/nrc2499-c1","article-title":"On the abundance of EpCAM on cancer stem cells","volume":"9","author":"Gires","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1038\/s41598-019-41941-4","article-title":"Ovarian cancer cell lines derived from non-serous carcinomas migrate and invade more aggressively than those derived from high-grade serous carcinomas","volume":"9","author":"Hallas-Potts","year":"2019","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/s41598-021-81126-6","article-title":"CD117\/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance","volume":"11","author":"Harris","year":"2021","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/carcin\/bgr257","article-title":"Upregulation of CD9 in ovarian cancer is related to the induction of TNF-\u03b1 gene expression and constitutive NF-\u03baB activation","volume":"33","author":"Hwang","year":"2012","journal-title":"Carcinogenesis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"24677","DOI":"10.18632\/oncotarget.8250","article-title":"Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer","volume":"7","author":"Hyun","year":"2016","journal-title":"Oncotarget"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","article-title":"A single-cell landscape of high-grade serous ovarian cancer","volume":"26","author":"Izar","year":"2020","journal-title":"Nat. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00404-003-0550-5","article-title":"A primary retroperitoneal serous cystadenocarcinoma with clinically aggressive behavior","volume":"270","author":"Kaku","year":"2004","journal-title":"Arch. Gynecol. Obstet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41388-021-02139-z","article-title":"Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence","volume":"41","author":"Kan","year":"2022","journal-title":"Oncogene"},{"key":"B18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3322\/caac.21559","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"B19","doi-asserted-by":"publisher","first-page":"17319","DOI":"10.1038\/srep17319","article-title":"Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol","volume":"5","author":"Livshits","year":"2015","journal-title":"Sci. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1177\/1535370220981855","article-title":"CD9, a tetraspanin target for cancer therapy?","volume":"246","author":"Lorico","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/cancers11060774","article-title":"Liquid biopsies for ovarian carcinoma: How blood tests may improve the clinical management of a deadly disease","volume":"11","author":"Mari","year":"2019","journal-title":"Cancers"},{"key":"B22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","article-title":"Identification of the tumour transition states occurring during EMT","volume":"556","author":"Pastushenko","year":"2018","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1159\/000499337","article-title":"Liquid biopsy: General concepts","volume":"63","author":"Poulet","year":"2019","journal-title":"Acta Cytol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.3390\/cancers13174318","article-title":"Malignant ascites in ovarian cancer: Cellular, acellular, and biophysical determinants of molecular characteristics and therapy response","volume":"13","author":"Rickard","year":"2021","journal-title":"Cancers"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1074\/mcp.M114.041194","article-title":"Proteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication","volume":"13","author":"Shender","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"7872","DOI":"10.3390\/ijms21217872","article-title":"New insights into therapy-induced progression of cancer","volume":"21","author":"Shnaider","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B27","first-page":"745","article-title":"Expression of CD133 and CD117 in 64 serous ovarian cancer cases","volume":"39","author":"Stemberger-Papi\u0107","year":"2015","journal-title":"Coll. Antropol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1756-9966-32-48","article-title":"Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: Basic knowledge and therapeutic possibilities for an innovative approach","volume":"32","author":"Tomao","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"R303","DOI":"10.1530\/ERC-17-0336","article-title":"Biomarkers of platinum resistance in ovarian cancer: What can we use to improve treatment","volume":"25","author":"van Zyl","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.2147\/OTT.S136549","article-title":"Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: Evidence from meta-analysis","volume":"10","author":"Yang","year":"2017","journal-title":"Onco. Targets. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semcancer.2021.03.032","article-title":"Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology","volume":"74","author":"Yokoi","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12943-022-01509-9","article-title":"Exosomes as a new frontier of cancer liquid biopsy","volume":"21","author":"Yu","year":"2022","journal-title":"Mol. Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"eabm1831","DOI":"10.1126\/sciadv.abm1831","article-title":"Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci. Adv."},{"key":"B34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","article-title":"Exosomes in cancer development, metastasis, and immunity","volume":"1871","author":"Zhang","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41392-020-00258-9","article-title":"Application of exosomes as liquid biopsy in clinical diagnosis","volume":"5","author":"Zhou","year":"2020","journal-title":"Signal Transduct. Target Ther."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1057484\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T11:38:19Z","timestamp":1676547499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1057484\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":35,"alternative-id":["10.3389\/fcell.2023.1057484"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2023.1057484","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"article-number":"1057484"}}